Infusion Pumps

Global Infusion Pumps Market to Reach US$19.2 Billion by 2030

The global market for Infusion Pumps estimated at US$14.5 Billion in the year 2024, is expected to reach US$19.2 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Volumetric Infusion Pumps, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$2.2 Billion by the end of the analysis period. Growth in the Insulin Infusion Pumps segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.7 Billion While China is Forecast to Grow at 7.8% CAGR

The Infusion Pumps market in the U.S. is estimated at US$3.7 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.5 Billion by the year 2030 trailing a CAGR of 7.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Infusion Pumps Market - Key Trends and Drivers Summarized

Infusion pumps are sophisticated medical devices used to administer fluids, such as nutrients and medications, into a patient’s body in precisely controlled amounts. These devices are critical in various healthcare settings, including hospitals, nursing homes, and increasingly in home care, to treat chronic diseases, manage pain, deliver chemotherapy, and provide parenteral nutrition. Infusion pumps are essential for the precise delivery of potent medications, including insulin for diabetes management, antibiotics for infection control, and chemotherapy drugs for cancer treatment. The main types of infusion pumps include volumetric pumps, which deliver large volumes of fluid; syringe pumps, which are used for small, precise volumes; and ambulatory pumps, designed for patient mobility. The precision and control offered by these devices significantly improve patient outcomes by ensuring accurate medication dosing, thereby reducing the risk of over or under-dosing and associated complications.

Technological advancements have significantly enhanced the functionality, safety, and efficiency of infusion pumps. Modern infusion pumps are equipped with sophisticated features such as dose error reduction systems (DERS) that help prevent medication errors by alerting users to potential issues like incorrect dosage settings. These pumps often incorporate wireless connectivity, enabling seamless integration with hospital information systems for real-time monitoring and data logging, which enhances patient safety and operational efficiency. The advent of smart pumps has been particularly transformative; these devices come with programmable drug libraries that standardize dosing parameters, thus minimizing the risk of human error. The development of wearable and portable infusion pumps has further broadened their application in home healthcare, allowing patients to maintain their mobility and quality of life while receiving continuous treatment. These innovations have made infusion pumps more user-friendly, reliable, and adaptable to various clinical and non-clinical environments.

The growth in the infusion pumps market is driven by several factors, including the increasing prevalence of chronic diseases such as diabetes, cancer, and chronic pain, which necessitate continuous and precise medication delivery. The rising geriatric population, more susceptible to chronic illnesses, further accelerates market demand. Technological innovations, such as the integration of wireless technology and advanced safety features, enhance the usability and reliability of infusion pumps, driving their adoption in both clinical and home settings. The growing trend towards home healthcare and outpatient care, driven by the need to reduce hospital stays and associated healthcare costs, expands the market for portable and wearable infusion pumps. Additionally, favorable reimbursement policies and increased healthcare spending in emerging economies contribute to the market`s expansion. The emphasis on improving patient safety and cost-effectiveness within healthcare systems worldwide further bolsters the demand for advanced infusion pump systems. As these trends continue, the infusion pumps market is poised for significant growth, supported by technological advancements and a growing focus on enhancing patient care and operational efficiency.

SCOPE OF STUDY:

The report analyzes the Infusion Pumps market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product Segment (Volumetric Infusion Pumps, Insulin Infusion Pumps, Ambulatory Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, PCA Infusion Pumps, Implantable Infusion Pumps, Accessories/Consumables); Application (Gastroenterology, Pediatrics/Neonatology, Diabetes, Analgesia/Pain Management, Chemotherapy/Oncology, Hematology, Other Applications); End-Use (Hospitals, Home Care Settings, Ambulatory Care Settings, Academic & Research Institutes)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 21 Featured) -

• Animas Corporation
• B. Braun Melsungen AG
• Baxter International Inc.
• Becton, Dickinson and Company
• F. Hoffmann-La Roche Ltd.
• Fresenius SE & Co. KGaA
• Halyard Health Inc.
• Hospira Inc.
• ICU Medical Inc.
• Insulet Corporation
• Medtronic Plc
• Moog Inc.
• Smiths Medical
• Sooil Development Co. Ltd.
• Tandem Diabetes Care Inc.
• Teleflex Inc.
• Terumo Corporation

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.